97 related articles for article (PubMed ID: 2057253)
1. Factor V inhibitor developing after liver transplantation in a 3-year-old child.
Gordon B; Haire W; Duggan M; Langnas A; Shaw B
Pediatrics; 1991 Jul; 88(1):156-9. PubMed ID: 2057253
[No Abstract] [Full Text] [Related]
2. Successful treatment with intravenous immunoglobulin (IVIg) in a patient with an acquired factor V inhibitor after liver transplantation.
Guglielmone H; Jarchum G; Minoldo S
Thromb Haemost; 2011 Nov; 106(5):985-6. PubMed ID: 21901236
[No Abstract] [Full Text] [Related]
3. Coagulation factors as indicators of early graft function following liver transplantation.
Forster J; Greig PD; Glynn MF; Poon A; Levy G; Superina RA; Langer B
Transplant Proc; 1989 Feb; 21(1 Pt 2):2308-10. PubMed ID: 2496499
[No Abstract] [Full Text] [Related]
4. Acquired factor V inhibitor in a critically ill patient.
Morris CJ; Curry N
Anaesthesia; 2009 Sep; 64(9):1014-7. PubMed ID: 19686488
[TBL] [Abstract][Full Text] [Related]
5. Factor V inhibitor associated with immune complex formation.
Lazarchick J; Wolff CM; Pepkowitz SH; Kizer J; Romein LA
Arch Pathol Lab Med; 1986 May; 110(5):448-51. PubMed ID: 3754431
[TBL] [Abstract][Full Text] [Related]
6. Laboratory measures of hemostasis for monitoring liver graft function.
Moia M; Martinelli I; Mannucci PM
Semin Thromb Hemost; 1993; 19(3):238-42. PubMed ID: 8362254
[No Abstract] [Full Text] [Related]
7. An acquired factor V inhibitor: clinical and laboratory features.
Shastri KA; Ho C; Logue G
J Med; 1999; 30(5-6):357-66. PubMed ID: 10851568
[TBL] [Abstract][Full Text] [Related]
8. A case report of an acquired inhibitor to coagulation factor V.
Shanmugam H; Jayaranee S; Eow GI
Haemophilia; 2011 Jan; 17(1):168-70. PubMed ID: 20557356
[No Abstract] [Full Text] [Related]
9. Development of factor V and thrombin inhibitors in children following bovine thrombin exposure during cardiac surgery: a report of three cases.
Bomgaars L; Carberry K; Fraser C; West A; Teruya J
Congenit Heart Dis; 2010; 5(3):303-8. PubMed ID: 20576051
[TBL] [Abstract][Full Text] [Related]
10. Biological changes after liver transplantation according to the presence or not of graft steatosis.
Muscari F; Guinard JP; Foppa B; Trocard P; Danjoux M; Kamel MS; Duffas JP; Rostaing L; Fourtanier G; Suc B
Transplant Proc; 2008 Dec; 40(10):3562-5. PubMed ID: 19100438
[TBL] [Abstract][Full Text] [Related]
11. [Massive bleeding symptoms in two patients with factor V inhibitor and antiphospholipid antibodies after treatment with ciprofloxacin].
Miesbach W; Voigt J; Peetz D; Scharrer I
Med Klin (Munich); 2003 Jun; 98(6):339-43. PubMed ID: 12811419
[TBL] [Abstract][Full Text] [Related]
12. Coagulation properties of fresh-frozin canine plasma during prolonged storage.
Greene CE; Beck BB
Am J Vet Res; 1980 Jan; 41(1):147-50. PubMed ID: 7362120
[TBL] [Abstract][Full Text] [Related]
13. Hemostatic problems in liver surgery.
Rö JS
Scand J Gastroenterol Suppl; 1973; 19():71-81. PubMed ID: 4577801
[No Abstract] [Full Text] [Related]
14. [Acquired factor V inhibitor treated with intravenous immunoglobulins].
Buclin T; Schmidt PM; Hauert J; Winkel L; Chapuis G; Bachmann F
Schweiz Med Wochenschr; 1992 Dec; 122(51-52):1968-70. PubMed ID: 1475662
[TBL] [Abstract][Full Text] [Related]
15. Blood clotting changes in guinea pigs with a heterologous intracranial neoplasm.
Hurt JP; Odom MH; Perlmutt L; Krigman MR
Lab Invest; 1970 Aug; 23(2):179-83. PubMed ID: 4317572
[No Abstract] [Full Text] [Related]
16. Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis.
Lian EC; Tzakis AG; Andrews D
Am J Hematol; 2004 Dec; 77(4):363-5. PubMed ID: 15551286
[TBL] [Abstract][Full Text] [Related]
17. Coagulation factors V and VII combined congenital deficiency in a Mexican family: Toledo-Tehuantepec deficiency, a new pathological entity.
Ambriz-Fernández R; Villaseñor A; Reyna MP; Pizzuto J; Guillén C
Arch Invest Med (Mex); 1985; 16(1):59-70. PubMed ID: 4015299
[No Abstract] [Full Text] [Related]
18. [Changes in factors of the prothrombin complex (prothrombin, proconvertin, proaccelerin) in chronic hepatitis and cirrhosis].
Stănescu M; Stroescu F
Med Interna (Bucur); 1967 Apr; 19(4):417-23. PubMed ID: 6052153
[No Abstract] [Full Text] [Related]
19. [High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].
Shimizu I; Ichikawa N; Yotsumoto M; Sumi M; Ueno M; Kobayashi H
Rinsho Ketsueki; 2008 Jun; 49(6):413-6. PubMed ID: 18646609
[TBL] [Abstract][Full Text] [Related]
20. [A case positive for the inhibitor for coagulation factor V].
Nakagoshi R; Takamiya O; Nakata S; Ishikawa S; Higuchi Y; Okumura N; Ogiso Y
Rinsho Byori; 1999 Oct; 47(10):971-5. PubMed ID: 10590673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
